|
|
 |
|
Viewing report
|
|
|
|
Cough and Cold Preparations Market in the Netherlands to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 28
Introduction
This databook provides key data and information on the Cough and Cold Preparations Market in the Netherlands (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The cough and cold preparations category was valued at €114.4m ($167.6m) in 2009, representing a CAGR of 2.8% since 2004.
By the end of 2014, the cough and cold preparations category will be worth €126.8m ($185.8m), with an expected CAGR of 2.1% between 2009 and 2014.
The cough and cold preparations market was led by mixtures (representing 36.6% of the total value) followed by lozenges and tablets, with a 24.3% and 18.1% market share, respectively. Inhalers and topical remedies constitute the remaining segments with a 13.8% and 7.3% market share, respectively.
Procter & Gamble Company is the market leader with a 35.5% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Cough and Cold Preparations Market in the Netherlands (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
